|
|
|
Volumn 26, Issue 1 SUPPL. 2, 1999, Pages 21-26
|
|
Paclitaxel plus nonanthracycline combinations in metastatic breast cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EDATREXATE;
EPIRUBICIN;
FLUOROURACIL;
FOLINATE CALCIUM;
GEMCITABINE;
GRANULOCYTE COLONY STIMULATING FACTOR;
IFOSFAMIDE;
LOSOXANTRONE;
MITOXANTRONE;
MONOCLONAL ANTIBODY;
NAVELBINE;
ORZEL;
PACLITAXEL;
PLATINUM DERIVATIVE;
TRASTUZUMAB;
UFT;
UNCLASSIFIED DRUG;
BONE MARROW TOXICITY;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CARDIOTOXICITY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG INDUCED DISEASE;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
METASTASIS;
MULTICENTER STUDY;
NEUROTOXICITY;
ORAL DRUG ADMINISTRATION;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
QUALITY OF LIFE;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CLINICAL TRIALS;
HUMANS;
NEOPLASM METASTASIS;
PACLITAXEL;
|
|
EID: 0032995227
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (6)
|
|
References (24)
|
